An official website of the United States government
Search Results
Search Results
April2025
S
M
T
W
R
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
April2025
S
M
T
W
R
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
All
Journals
Podcasts
Results returned for Venetoclaxfrom all of CDC.gov
Where is Cancer Precision Medicine Today? Most of the early successes of precision medicine have been in cancer. Drugs such as imatinib (Gleevec) and venetoclax can treat cancers caused by specific genetic changes. Imatinib…Read more
Disease course, day† Clinical manifestations Treatment/action Clinical samples‡ RT-PCR results (mean Ct value) VirSNIP Kit results NGS clade ‒20 First dose mRNA vaccine§ ‒17 Venetoclax, rituximab ‒4 Cough, fever, diarrhea, asthenia…Read more
This assay showed a cycle threshold (Ct) value of 27 for a nasopharyngeal swab specimen. His most recent monoclonal antibody (mAb) chemotherapy treatment (venetoclax and ritux- imab) had been conducted 17 days earlier. Because…Read more
We report a case of ocular-only mpox infection in a 53-year-old man in San Francisco, California, USA. His medical history included chronic lymphocytic leukemia (CLL), inactive 2 years after treatment with obinutuzumab and venetoclax…Read more
The man’s leukemia relapsed 6 months after his original diagnosis, and he received treatment that included cyclophosphamide, vincristine, doxorubicin, methotrexate, cytarabine, dexamethasone, dasatinib, and venetoclax. At 4…Read more
This assay showed a cycle threshold (Ct) value of 27 for a nasopharyngeal swab specimen. His most recent monoclonal antibody (mAb) chemotherapy treatment (venetoclax and rituximab) had been conducted 17 days earlier. Because…Read more
Therefore, therapy with enasidenib, an isocitrate dehydrogenase 2 gene blocker, was initiated. She showed a good response for 8 months. Near the time of her admission, the disease progressed, and venetoclax, a B-cell lymphoma…Read more
Therefore, therapy with enasidenib, an isocitrate dehydrogenase 2 gene blocker, was initiated. She showed a good response for 8 months. Near the time of her admission, the dis- ease progressed, and venetoclax, a B-cell lymphoma…Read more
The man’s leukemia relapsed 6 months after his original diagnosis, and he received treatment that included cyclophosphamide, vincristine, doxorubi- cin, methotrexate, cytarabine, dexamethasone, da- satinib, and venetoclax. At…Read more
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 29, No. 6, June 2023 1283 RESEARCH LETTERS 8. Menning CB. The noble hunt: the “Libro della caccia” of Angelo del Bufalo. Yale Univ Libr Gaz. 2001;76:27–35. 9. Fornaciari G, Giuffra…Read more
Please use the search area above.
Please use the search area above.
Content Credential